| Announce Date | 02/03/2026 |
| EPS Normalized Actual | $17.03 (Beat by $6.44) |
| EPS GAAP Actual | $17.03 (Beat by $6.44) |
| Revenue Actual | $2.97B |
| Revenue Surprise | Beat by $2970M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 36.66 | 8.32 | 34.00213 | 39.80445 | 0 |
| Dec 2027 | 35.21 | 8.66 | 32.65725 | 38.23008 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 16.75 | 16.75 | 2.97B | 23.27% | 2970M |
| FQ3 2025 (Sep 2025) | 19.47 | 19.47 | 3.14799B | -19.23% | 3147.99M |
| FQ2 2025 (Jun 2025) | 17.25 | 17.25 | 3.13043B | 9.77% | 3130.43M |
| FQ1 2025 (Mar 2025) | 3.29 | 3.29 | 3.47049B | 25.1% | 3470.49M |
| FQ4 2024 (Dec 2024) | -3.84 | -3.84 | 2.27878B | -41.52% | 2278.78M |
| FQ3 2024 (Sep 2024) | 23.03 | 23.03 | 3.75333B | 51.08% | 3753.33M |
| FQ2 2024 (Jun 2024) | 9.61 | 9.61 | 2.82458B | 34.39% | 2824.58M |
| FQ1 2024 (Mar 2024) | 6.96 | 6.96 | 2.59943B | 15.17% | 2599.43M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 11.243 | -- | 10.85656 | 11.69588 | 1 |
| FQ3 2028 (Sep 2028) | 5.76795 | -- | 5.5697 | 6.00029 | 1 |
| FQ2 2028 (Jun 2028) | 13.1359 | -- | 12.6844 | 13.66503 | 1 |
| FQ1 2028 (Mar 2028) | 12.90135 | -- | 12.45791 | 13.42103 | 1 |
| FQ4 2027 (Dec 2027) | 9.91794 | -- | 9.57705 | 10.31745 | 1 |
| FQ3 2027 (Sep 2027) | 6.37147 | -- | 6.15247 | 6.62812 | 1 |
| FQ2 2027 (Jun 2027) | 11.83454 | -- | 11.42777 | 12.31125 | 1 |
| FQ1 2027 (Mar 2027) | 13.0205 | -- | 12.46036 | 13.60079 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.83B | -- | 1.78B | 1.89B | 1 |
| FQ3 2028 (Sep 2028) | 2.2B | -- | 2.14B | 2.27B | 1 |
| FQ2 2028 (Jun 2028) | 2.97B | -- | 2.89B | 3.06B | 1 |
| FQ1 2028 (Mar 2028) | 3.29B | -- | 3.21B | 3.4B | 1 |
| FQ4 2027 (Dec 2027) | 2.16B | -- | 2.1B | 2.22B | 2 |
| FQ3 2027 (Sep 2027) | 2.43B | -- | 2.36B | 2.5B | 2 |
| FQ2 2027 (Jun 2027) | 2.94B | -- | 2.86B | 3.03B | 2 |
| FQ1 2027 (Mar 2027) | 6.6B | -- | 6.39B | 6.83B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 16.75 | 16.75 | 100% | |
| FQ3 2025 (Sep 2025) | 19.47 | 19.47 | 100% | |
| FQ2 2025 (Jun 2025) | 17.25 | 17.25 | 100% | |
| FQ1 2025 (Mar 2025) | 3.29 | 3.29 | 100% | |
| FQ4 2024 (Dec 2024) | -3.84 | -3.84 | 100% | |
| FQ3 2024 (Sep 2024) | 23.03 | 23.03 | 100% | |
| FQ2 2024 (Jun 2024) | 9.61 | 9.61 | 100% | |
| FQ1 2024 (Mar 2024) | 6.96 | 6.96 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $2.97B | $2970M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $3.15B | $3147.99M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $3.13B | $3130.43M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.47B | $3470.49M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.28B | $2278.78M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.75B | $3753.33M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.82B | $2824.58M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.6B | $2599.43M | 100% |